Year-End Report 2023 (Only in Swedish)
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Revenue increased in the fourth quarter by 25.0 percent to 77.3 MSEK (61.8) with strong growth from both business units. “I am pleased to note that our growth momentum remains strong in the fourth quarter, and we continue to deliver on our growth strategy. 2023 marked a significant milestone for Stille.”, comments Torbjörn Sköld, referencing the acquisition of the German family-owned company Fehling Instruments, announced during the fourth quarter.
"With this acquisition, Stille significantly broadens its product portfolio and further strengthens its position in strategically important markets within the premium surgical instrument segment”, says Torbjörn Sköld, expressing satisfaction with the successful share issue that financed the acquisition. “The remarkable interest in Stille meant that the share issue, despite the current business climate, was carried out at a premium to the then-current stock price, strengthening our already robust shareholder base with new, long-term, sector-specific owners."
The gross profit amounted to 45.6 percent (45.8). Business unit Surgical Tables was affected by an unfavorable product
and market mix. Operating profit amounted to 14.0 MSEK (8.8).
”2023 ends very strongly, and we look forward to 2024”, concludes Stille’s CEO.
| MSEK | OCT-DEC 2023 |
OCT-DEC 2022 |
JAN-DEC 2023 |
JAN-DEC 2022 |
| Revenue | 77.3 | 61.8 | 294.9 | 246.3 |
| Gross Profit Margin, % | 45.6 | 45.8 | 44.8 | 45.3 |
| EBITDA, before one-time costs | 17.7 | 11.7 | 62.6 | 42.1 |
| EBITDA | 17.7 | 11.6 | 59.3 | 42.1 |
| EBITDA, % | 22.9 | 18.8 | 20.1 | 17.1 |
| Operating Profit, before one-time costs | 14.0 | 8.8 | 48.3 | 32.5 |
| Operating Profit | 14.0 | 8.8 | 45.0 | 32.4 |
| Operating Profit, % | 18.1 | 14.2 | 15.2 | 13.2 |
Torshälla, February 16th, 2024.
This information is such information that Stille AB is obliged to disclose according to the EU’s market abuse regulation. The information was, through the agency of the contact person, rendered for publication on February 16th, 2024, kl. 08.00 (CET).